Cargando…
Lithium-induced Hyperparathyroidism and Hypercalcemia
Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609280/ https://www.ncbi.nlm.nih.gov/pubmed/31309015 http://dx.doi.org/10.7759/cureus.4590 |
_version_ | 1783432283982659584 |
---|---|
author | Naramala, Srikanth Dalal, Hussain Adapa, Sreedhar Hassan, Amir Konala, Venu Madhav |
author_facet | Naramala, Srikanth Dalal, Hussain Adapa, Sreedhar Hassan, Amir Konala, Venu Madhav |
author_sort | Naramala, Srikanth |
collection | PubMed |
description | Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed the pathophysiology and management of hyperparathyroidism and hypercalcemia in patients on chronic lithium therapy. |
format | Online Article Text |
id | pubmed-6609280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-66092802019-07-15 Lithium-induced Hyperparathyroidism and Hypercalcemia Naramala, Srikanth Dalal, Hussain Adapa, Sreedhar Hassan, Amir Konala, Venu Madhav Cureus Endocrinology/Diabetes/Metabolism Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed the pathophysiology and management of hyperparathyroidism and hypercalcemia in patients on chronic lithium therapy. Cureus 2019-05-02 /pmc/articles/PMC6609280/ /pubmed/31309015 http://dx.doi.org/10.7759/cureus.4590 Text en Copyright © 2019, Naramala et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Naramala, Srikanth Dalal, Hussain Adapa, Sreedhar Hassan, Amir Konala, Venu Madhav Lithium-induced Hyperparathyroidism and Hypercalcemia |
title | Lithium-induced Hyperparathyroidism and Hypercalcemia |
title_full | Lithium-induced Hyperparathyroidism and Hypercalcemia |
title_fullStr | Lithium-induced Hyperparathyroidism and Hypercalcemia |
title_full_unstemmed | Lithium-induced Hyperparathyroidism and Hypercalcemia |
title_short | Lithium-induced Hyperparathyroidism and Hypercalcemia |
title_sort | lithium-induced hyperparathyroidism and hypercalcemia |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609280/ https://www.ncbi.nlm.nih.gov/pubmed/31309015 http://dx.doi.org/10.7759/cureus.4590 |
work_keys_str_mv | AT naramalasrikanth lithiuminducedhyperparathyroidismandhypercalcemia AT dalalhussain lithiuminducedhyperparathyroidismandhypercalcemia AT adapasreedhar lithiuminducedhyperparathyroidismandhypercalcemia AT hassanamir lithiuminducedhyperparathyroidismandhypercalcemia AT konalavenumadhav lithiuminducedhyperparathyroidismandhypercalcemia |